为了使您在Abcam官网的浏览体验更顺畅，请使用最新版本的浏览器比如 Google Chrome
Cancer immunotherapies are efficient and have durable effects, but to fully unleash the power of immunotherapy against cancer requires identification of biomarkers to predict patient response.
To support you in your research to identify immuno-oncology biomarkers, our comprehensive range of flexible and validated immuno-oncology tools is on hand.
Take a flexible approach
Our antibodies to immuno-oncology targets are available in multiple formats: whether you are looking for a conjugated primary antibody, ELISA kit, or BSA-only formulation, search our catalog to find the right format for your research.
Generate data you can trust
To give you specific and reproducible results, our antibodies are supported by extensive data and validation in relevant applications. Our immuno-oncology range also includes knockout-validated antibodies for confirmed specificity.
PD-L1 is a key biomarker for cancer therapeutic efficacy. Study PD-L1 from every angle with our knockout-validated PD-L1 [clone 28-8] rabbit monoclonal antibody. With no cross-reactivity to PD-L2 you can ensure you generate specific and sensitive data.
Figure 1. Knock-out validation results using PD-L1 [28-8] rabbit monoclonal antibody. Left wild type L2987 cells, right PD-L1 KB L2987 cells.
Also in the range:
CTLA-4 and PD-1
Check in with the important immune checkpoint proteins CTLA-4 and PD-1 with our conjugated and unconjugated primary antibodies:
|Primary antibody||Anti-CTLA-4 [BNI3] antibody||Anti-PD1 [NAT105] antibody|
|Primary conjugates||Alexa Fluor® 488||Alexa Fluor® 647, Alexa Fluor® 488|
Activate your immune response and your research with our conjugated and unconjugated antibodies to CXCR4:
Investigate TNF-alpha in your immuno-oncology research:
Can't see what you need? Whatever immuno-oncology targets you are investigating, find the products you need on our extensive catalog. Start here.
Alexa Fluor® is a registered trademark of Life Technologies. Alexa Fluor® dye conjugates contain(s) technology licensed to Abcam by Life Technologies.